FI943976A7 - 5-arylindolderivat - Google Patents

5-arylindolderivat

Info

Publication number: FI943976A7
Authority: FI; Finland
Prior art keywords: arylindole derivatives; arylindole; derivatives
Prior art date: 1993-08-31

Application number

FI943976A

Other languages

English (en)

Finnish (fi)

Other versions

FI113536B (sv

FI943976A0 (sv

Inventor

John E Macor

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-08-31

Filing date

1994-08-30

Publication date

1995-03-01

1994-08-30 Application filed by Pfizer filed Critical Pfizer

1994-08-30 Publication of FI943976A0 publication Critical patent/FI943976A0/sv

1995-03-01 Publication of FI943976A7 publication Critical patent/FI943976A7/sv

2004-05-14 Application granted granted Critical

2004-05-14 Publication of FI113536B publication Critical patent/FI113536B/sv

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Cardiology (AREA)
Addiction (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FI943976A 1993-08-31 1994-08-30 Förfarande för framställning av terapeutiskt användbara 5-arylindolderivat FI113536B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11528293A	1993-08-31	1993-08-31
US11528293		1993-08-31

Publications (3)

Publication Number	Publication Date
FI943976A0 FI943976A0 (sv)	1994-08-30
FI943976A7 true FI943976A7 (sv)	1995-03-01
FI113536B FI113536B (sv)	2004-05-14

Family

ID=22360355

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI943976A FI113536B (sv)	1993-08-31	1994-08-30	Förfarande för framställning av terapeutiskt användbara 5-arylindolderivat

Country Status (26)

Country	Link
US (3)	US5849739A (sv)
EP (1)	EP0716649B1 (sv)
JP (1)	JP2860603B2 (sv)
KR (1)	KR100191973B1 (sv)
CN (1)	CN1129933A (sv)
AT (1)	ATE170836T1 (sv)
AU (1)	AU686654B2 (sv)
BR (1)	BR9407402A (sv)
CA (1)	CA2169179C (sv)
CO (1)	CO4230238A1 (sv)
CZ (1)	CZ59996A3 (sv)
DE (1)	DE69413240T2 (sv)
DK (1)	DK0716649T3 (sv)
EC (1)	ECSP941122A (sv)
EG (1)	EG20547A (sv)
ES (1)	ES2122289T3 (sv)
FI (1)	FI113536B (sv)
HU (1)	HUT75646A (sv)
IL (1)	IL110773A (sv)
MY (1)	MY111127A (sv)
NO (1)	NO960818D0 (sv)
NZ (1)	NZ267487A (sv)
PE (1)	PE11895A1 (sv)
PL (1)	PL177604B1 (sv)
WO (1)	WO1995006636A1 (sv)
ZA (1)	ZA946608B (sv)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5559246A (en) *	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
US5607951A (en) *	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
US5559129A (en) *	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
US5578612A (en) *	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5545644A (en) *	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
DK0716649T3 (da) *	1993-08-31	1999-02-08	Pfizer	5-Arylindolderivater
GB9417310D0 (en)	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
GB9420529D0 (en)	1994-10-12	1994-11-30	Pfizer Ltd	Indoles
EP0844996A1 (en) *	1995-08-07	1998-06-03	MERCK SHARP & DOHME LTD.	Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
DE69819903T2 (de)	1997-08-09	2004-11-11	Smithkline Beecham P.L.C., Brentford	Bicyclische verbindungen als liganden der 5-ht1 rezeptoren
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
AU3170099A (en) *	1998-04-16	1999-11-08	Yamanouchi Pharmaceutical Co., Ltd.	Remedies for obesity
US5994352A (en) *	1998-11-13	1999-11-30	Pfizer Inc.	5-arylindole derivatives
PE20020506A1 (es)	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
US6670362B2 (en)	2000-09-20	2003-12-30	Pfizer Inc.	Pyridazine endothelin antagonists
GB0124939D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124933D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124931D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124941D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124938D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124936D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124934D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
DE10159922A1 (de) *	2001-12-06	2003-06-26	Gruenenthal Gmbh	Substituierte 2-Pyrrolidin-2-yl-1H-indol-Derivate
EP2258687B1 (en)	2002-02-12	2012-12-26	Glaxosmithkline LLC	Nicotinamide derivates useful as P38 inhibitors
US7332508B2 (en) *	2002-12-18	2008-02-19	Novo Nordisk A/S	Substituted homopiperidine, piperidine or pyrrolidine derivatives
GB0308186D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0308201D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0308185D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0318814D0 (en)	2003-08-11	2003-09-10	Smithkline Beecham Corp	Novel compounds
WO2005066157A1 (en) *	2004-01-02	2005-07-21	Suven Life Sciences	3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators
US7223994B2 (en) *	2004-06-03	2007-05-29	International Business Machines Corporation	Strained Si on multiple materials for bulk or SOI substrates
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
US10336701B2 (en)	2017-08-10	2019-07-02	Janssen Pharmaceutica Nv	Pyridin-2-one derivatives of formula (II) useful as EP3 receptor antagonists
US10399944B2 (en)	2017-08-10	2019-09-03	Janssen Pharmaceutica Nv	Pyridin-2-one derivatives of formula (III) useful as EP3 receptor antagonists
US10590083B2 (en)	2017-08-10	2020-03-17	Janssen Pharmaceutica Nv	Pyridin-2-one derivatives of formula (I) useful as EP3 receptor antagonists

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2773875A (en) *	1952-03-28	1956-12-11	Hoffmann La Roche	Indole derivatives and method for producing same
GB886684A (en) *	1957-09-17	1962-01-10	Upjohn Co	Improvements in or relating to heterocyclic compounds and the manufacture thereof
GB851780A (en) *	1958-02-25	1960-10-19	Rhone Poulenc Sa	New indole derivatives
US3037031A (en) *	1959-08-04	1962-05-29	Warner Lambert Pharmaceutical	Derivatives of 3-(2-aminoalkyl)-5-indolol and process therefor
GB893707A (en) *	1960-03-01	1962-04-11	Roche Products Ltd	Novel tryptamine derivatives and a process for the manufacture thereof
GB966562A (en) *	1961-04-06	1964-08-12	Parke Davis & Co	Amine compounds and means of producing the same
ZA795239B (en) *	1978-10-12	1980-11-26	Glaxo Group Ltd	Heterocyclic compounds
ZW19381A1 (en) *	1980-08-12	1983-03-09	Glaxo Group Ltd	Heterocyclic compounds
US4803218A (en) *	1982-09-29	1989-02-07	Mcneilab, Inc.	3-aminoalkyl-1H-indole-5-urea and amide derivatives
GB8600397D0 (en) *	1986-01-08	1986-02-12	Glaxo Group Ltd	Chemical compounds
IL96891A0 (en) *	1990-01-17	1992-03-29	Merck Sharp & Dohme	Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
MC2210A1 (fr) *	1990-06-07	1992-11-26	Wellcome Found	Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer
DK158590D0 (da) *	1990-07-02	1990-07-02	Lundbeck & Co As H	Indolderivater
US5607951A (en) *	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
US5545644A (en) *	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5578612A (en) *	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5559129A (en) *	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
ES2104733T3 (es) *	1990-10-15	1997-10-16	Pfizer	Derivados de indol.
US5208248A (en) *	1991-01-11	1993-05-04	Merck Sharpe & Dohme, Ltd.	Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) *	1991-02-01	1998-05-06	Merck Sharp & Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu, spôsob i
ATE190608T1 (de) *	1991-11-25	2000-04-15	Pfizer	5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten
GB9201038D0 (en) *	1992-01-16	1992-03-11	Glaxo Group Ltd	Chemical compounds
US5409941A (en) *	1992-02-03	1995-04-25	Pfizer Inc.	5-heteroyl indole derivatives
TW288010B (sv) *	1992-03-05	1996-10-11	Pfizer
UA27467C2 (uk) *	1992-04-07	2000-09-15	Пфайзер Інк.	ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
CZ282653B6 (cs) *	1992-04-10	1997-08-13	Pfizer Inc.	Acylaminoindolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy
GB9207930D0 (en) *	1992-04-10	1992-05-27	Pfizer Ltd	Indoles
GB9208161D0 (en) *	1992-04-14	1992-05-27	Pfizer Ltd	Indoles
GB9210400D0 (en) *	1992-05-15	1992-07-01	Merck Sharp & Dohme	Therapeutic agents
TW251284B (sv) *	1992-11-02	1995-07-11	Pfizer
GB9226532D0 (en) *	1992-12-21	1993-02-17	Smithkline Beecham Plc	Compounds
FR2701026B1 (fr) *	1993-02-02	1995-03-31	Adir	Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0695301B1 (en) *	1993-04-22	1996-10-30	Pfizer Limited	Indole derivatives as 5-ht1-like agonists for use in migraine
AP486A (en) *	1993-04-27	1996-04-16	Pfizer	Indole derivatives.
DK0716649T3 (da) *	1993-08-31	1999-02-08	Pfizer	5-Arylindolderivater

1994
- 1994-07-04 DK DK94918494T patent/DK0716649T3/da active
- 1994-07-04 AT AT94918494T patent/ATE170836T1/de not_active IP Right Cessation
- 1994-07-04 EP EP94918494A patent/EP0716649B1/en not_active Expired - Lifetime
- 1994-07-04 AU AU69796/94A patent/AU686654B2/en not_active Ceased
- 1994-07-04 KR KR1019960701010A patent/KR100191973B1/ko not_active Expired - Fee Related
- 1994-07-04 JP JP7508024A patent/JP2860603B2/ja not_active Expired - Fee Related
- 1994-07-04 CN CN94193224A patent/CN1129933A/zh active Pending
- 1994-07-04 WO PCT/IB1994/000195 patent/WO1995006636A1/en not_active Ceased
- 1994-07-04 ES ES94918494T patent/ES2122289T3/es not_active Expired - Lifetime
- 1994-07-04 DE DE69413240T patent/DE69413240T2/de not_active Expired - Fee Related
- 1994-07-04 US US08/600,931 patent/US5849739A/en not_active Expired - Fee Related
- 1994-07-04 BR BR9407402A patent/BR9407402A/pt not_active Application Discontinuation
- 1994-07-04 CA CA002169179A patent/CA2169179C/en not_active Expired - Fee Related
- 1994-07-04 HU HU9600509A patent/HUT75646A/hu unknown
- 1994-07-04 CZ CZ96599A patent/CZ59996A3/cs unknown
- 1994-07-20 EC EC1994001122A patent/ECSP941122A/es unknown
- 1994-08-03 PE PE1994247898A patent/PE11895A1/es not_active Application Discontinuation
- 1994-08-25 IL IL11077394A patent/IL110773A/en not_active IP Right Cessation
- 1994-08-26 MY MYPI94002252A patent/MY111127A/en unknown
- 1994-08-28 EG EG52794A patent/EG20547A/xx active
- 1994-08-30 FI FI943976A patent/FI113536B/sv not_active IP Right Cessation
- 1994-08-30 ZA ZA946608A patent/ZA946608B/xx unknown
- 1994-08-31 CO CO94038859A patent/CO4230238A1/es unknown
1996
- 1996-02-08 NZ NZ267487A patent/NZ267487A/en unknown
- 1996-02-08 PL PL94313227A patent/PL177604B1/pl unknown
- 1996-02-28 NO NO960818A patent/NO960818D0/no not_active Application Discontinuation
1998
- 1998-11-13 US US09/191,130 patent/US6093822A/en not_active Expired - Fee Related
- 1998-11-13 US US09/191,350 patent/US5942524A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO960818L (no)	1996-02-28
AU6979694A (en)	1995-03-22
PL313227A1 (en)	1996-06-10
ECSP941122A (es)	1994-12-15
EG20547A (en)	1999-07-31
ZA946608B (en)	1996-02-28
US6093822A (en)	2000-07-25
CN1129933A (zh)	1996-08-28
KR100191973B1 (ko)	1999-06-15
BR9407402A (pt)	1996-11-05
ATE170836T1 (de)	1998-09-15
AU686654B2 (en)	1998-02-12
JPH08511032A (ja)	1996-11-19
CA2169179C (en)	2000-02-29
EP0716649A1 (en)	1996-06-19
JP2860603B2 (ja)	1999-02-24
CZ59996A3 (en)	1996-06-12
KR960704843A (ko)	1996-10-09
US5942524A (en)	1999-08-24
DE69413240D1 (en)	1998-10-15
EP0716649B1 (en)	1998-09-09
MY111127A (en)	1999-08-30
NO960818D0 (no)	1996-02-28
PE11895A1 (es)	1995-05-12
ES2122289T3 (es)	1998-12-16
NZ267487A (en)	1997-09-22
CO4230238A1 (es)	1995-10-19
IL110773A (en)	2001-06-14
FI113536B (sv)	2004-05-14
FI943976A0 (sv)	1994-08-30
IL110773A0 (en)	1999-04-11
HUT75646A (en)	1997-05-28
CA2169179A1 (en)	1995-03-09
PL177604B1 (pl)	1999-12-31
HU9600509D0 (en)	1996-04-29
DK0716649T3 (da)	1999-02-08
WO1995006636A1 (en)	1995-03-09
DE69413240T2 (de)	1999-02-04
US5849739A (en)	1998-12-15

Publication	Publication Date	Title
FI943976A7 (sv)	1995-03-01	5-arylindolderivat
FI930208L (fi)	1993-07-21	Kinazolinderivat
FI935431A7 (sv)	1994-06-11	Kinazolinderivat
FI980341L (sv)	1998-02-13	2-oxindolderivat
ATA75293A (de)	1997-11-15	Indolderivate
FI933037A7 (fi)	1994-01-03	Tiazolylvinylfenylderivat
FI941423A7 (sv)	1994-05-27	17beta-substituerade 4-aza-5alfa-androstan-3-onderivat
FI945674A7 (sv)	1995-06-03	Substituerade 2beta-morfolin-androstanderivat
DE69330497D1 (de)	2001-08-30	Chinazolin-derivate
FI20010214A7 (sv)	2001-02-05	Acylaminoindolderivat
FI942444A7 (sv)	1994-11-28	Tetrahydropyranderivat
FI943885L (sv)	1995-02-25	Penamderivat
DE59308714D1 (de)	1998-07-30	Cyclobutan-benzol-derivate
FI20002460A7 (sv)	2000-11-09	4-difenylmetylpiperidinderivat
FI944044L (sv)	1995-03-03	Fenylalkanolaminderivat
NO952288D0 (no)	1995-06-09	Benzazepinon-derivater
DE69313890D1 (de)	1997-10-23	5-Aminoflavon-Derivate
FI930367L (fi)	1993-08-01	Puridinderivat
ATA212793A (de)	1996-01-15	Sportschuh
ATA194593A (de)	1996-01-15	Sportschuh
ATA179094A (de)	1997-07-15	Kettenschloss
DE59407726D1 (de)	1999-03-11	3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
FI930934L (fi)	1993-09-05	Tetrahydropyrimidinderivat
FI930922A7 (fi)	1993-09-04	Substituerade fenylkinazolinderivat
FI930873A7 (fi)	1993-08-29	Tetrahydrotiofenderivat

Legal Events

Date	Code	Title	Description
2006-02-28	MA	Patent expired